Biomarker Identification

You are here: Home » Services » Biomarker Identification

Biomarker identification, selection and clinical validation presents many challenges. We can help you solve them.

Biomarkers are pivotal in diagnostics and drug development. Are you finding the most sensitive, specific, and reproducible multi-marker signatures?

Ariana helps you develop robust biomarker signatures and find the best combinations of biomarkers in your data. It’s the only FDA-tested technology that explores the entire combinatorial space to supply you with the best, most cost-effective signatures.

We deliver the actionable information you need to support your development processes: with our KEM® (Knowledge, Extraction, Management) process, we integrate and analyze multi-parametric data to provide you with the most relevant combinations of markers and patient characteristics.

Our platform handles any kind of relevant data you provide, including clinical, imaging, biochemical, NGS/genomic/proteomic/transcriptomic, genetic, patient characteristics and more.

Faster, cheaper product development and approval